{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T13:38:18Z","timestamp":1777469898596,"version":"3.51.4"},"reference-count":0,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BD"],"published-print":{"date-parts":[[2011,7,11]]},"DOI":"10.3233\/bd-2010-0325","type":"journal-article","created":{"date-parts":[[2016,6,22]],"date-time":"2016-06-22T14:51:11Z","timestamp":1466607071000},"page":"71-81","source":"Crossref","is-referenced-by-count":4,"title":["Intravenous bisphosphonates for breast cancer: Impact on patient outcomes and scientific concepts"],"prefix":"10.1177","volume":"33","author":[{"given":"Michael","family":"Gnant","sequence":"first","affiliation":[{"name":"Medical University of Vienna, Vienna, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","container-title":["Breast Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/BD-2010-0325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:37:40Z","timestamp":1777383460000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/BD-2010-0325"}},"subtitle":[],"editor":[{"given":"Rowan T.","family":"Chlebowski","sequence":"additional","affiliation":[{"name":"Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA"}],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,7,11]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/bd-2010-0325","relation":{},"ISSN":["1558-1551","0888-6008"],"issn-type":[{"value":"1558-1551","type":"electronic"},{"value":"0888-6008","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,11]]}}}